Deals
Life Technologies Buys Navigenics for Genetic Diagnostics
This article is for subscribers only.
Life Technologies Corp., the maker of machines that decode human DNA, purchased closely held Navigenics Inc., bolstering its ability to provide gene diagnostics in a fast-growing market.
The acquisition was announced today in a statement from Carlsbad, California-based Life Technologies. Terms of the sale weren’t disclosed. Navigenics’s government-approved medical genetics laboratory and data systems will speed development of tests that help doctors prescribe cancer drugs, said Greg Lucier, Life’s chairman and chief executive officer.